Breast Cancer Research and Treatment

, Volume 121, Issue 2, pp 413–419 | Cite as

Three versus six months of exercise training in breast cancer survivors

  • Lisa K. Sprod
  • City C. Hsieh
  • Reid Hayward
  • Carole M. SchneiderEmail author
Clinical trial


Breast cancer is the most prevalent type of cancer in American women. Exercise appears to diminish many of the side effects resulting from breast cancer and its treatment. Very little research, however, has compared the outcomes of varying lengths of combined aerobic and resistance training exercise interventions on physiological and psychological parameters in breast cancer survivors. The purpose of this study was to compare the physiological and psychological outcomes following 3 and 6 months of exercise in breast cancer survivors. Breast cancer survivors (N = 114) participated in either 3 months of prescriptive, individualized exercise (3M; n = 29), 6 months of prescriptive, individualized exercise (6M; n = 68), or served as sedentary controls (C; n = 17). Cancer survivors completed a medical evaluation and assessment at baseline followed by a predetermined 3- or 6-month exercise intervention. Cancer survivors in the control group performed no exercise between the initial assessment and 6-month reassessment. Cardiovascular endurance, pulmonary function, muscular endurance, fatigue, and symptoms of depression were assessed at baseline and post intervention. Repeated measures ANCOVA revealed improvements (P < 0.05) in cardiovascular endurance, fatigue, and symptoms of depression in breast cancer survivors undergoing 3- and 6-month individualized exercise interventions. Breast cancer survivors exercising for 6 months showed additional improvements (P < 0.05) in pulmonary function and muscular endurance. Cancer survivors in the control group did not improve in cardiovascular endurance, pulmonary function, muscular endurance, or fatigue. Three months of individualized, prescriptive exercise leads to improved cardiovascular endurance, fatigue, and symptoms of depression in breast cancer survivors. Additional benefits are seen if exercise is continued for a total of 6 months.


Breast cancer survivors Cancer-related fatigue Depression Exercise Muscular endurance Pulmonary function 


  1. 1.
    American Cancer Society (2009) Cancer facts and figures. American Cancer Society, AtlantaGoogle Scholar
  2. 2.
    DeVita VT, Hellman S, Rosenberg SA (2005) Cancer, principles & practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, Ixxv, 2898 ppGoogle Scholar
  3. 3.
    Hayes S, Battistutta D, Newman B (2005) Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat 94(1):1–10CrossRefPubMedGoogle Scholar
  4. 4.
    Westrup JL et al (2006) Risk of decline in upper-body function and symptoms among older breast cancer patients. J Gen Intern Med 21(4):327–333CrossRefPubMedGoogle Scholar
  5. 5.
    Albert US et al (2006) Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat 100(3):285–292CrossRefPubMedGoogle Scholar
  6. 6.
    Blomqvist L et al (2004) Evaluation of arm and shoulder mobility and strength after modified radical mastectomy and radiotherapy. Acta Oncol 43(3):280–283CrossRefPubMedGoogle Scholar
  7. 7.
    Box RC et al (2002) Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res Treat 75(1):35–50CrossRefPubMedGoogle Scholar
  8. 8.
    Shamley DR et al (2007) Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat 106(1):19–27CrossRefPubMedGoogle Scholar
  9. 9.
    Leidenius M et al (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92(1):23–31CrossRefPubMedGoogle Scholar
  10. 10.
    Pyszel A et al (2006) Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39(4):185–192PubMedGoogle Scholar
  11. 11.
    Dow KH (2004) Contemporary issues in breast cancer: a nursing perspective, 2nd ed. Jones and Bartlett series in oncology. Jones and Bartlett, Sudbury, xvi, 349 ppGoogle Scholar
  12. 12.
    Nygren P (2001) What is cancer chemotherapy? Acta Oncol 40:166–174CrossRefPubMedGoogle Scholar
  13. 13.
    Doyle JJ et al (2005) Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 23(34):8597–8605CrossRefPubMedGoogle Scholar
  14. 14.
    Meinardi MT et al (2002) Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques. Heart 88(1):81–82CrossRefPubMedGoogle Scholar
  15. 15.
    Erselcan T et al (2000) Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer. Br J Cancer 82(4):777–781CrossRefPubMedGoogle Scholar
  16. 16.
    de Graaf H et al (1997) Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer. Br J Cancer 76(7):943–945PubMedGoogle Scholar
  17. 17.
    Wilczynski SW et al (1998) Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 157(2):565–573PubMedGoogle Scholar
  18. 18.
    Chap L et al (1997) Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone Marrow Transplant 20(12):1063–1067CrossRefPubMedGoogle Scholar
  19. 19.
    Hurria A et al (2006) A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc 54(7):1119–1124CrossRefPubMedGoogle Scholar
  20. 20.
    Moon YW et al (2005) Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis. Ann Oncol 16(11):1778–1785CrossRefPubMedGoogle Scholar
  21. 21.
    Erman M et al (2005) A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer. Cancer Investig 23(3):215–221CrossRefGoogle Scholar
  22. 22.
    Vassilomanolakis M et al (2005) First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer. Breast 14(2):136–141CrossRefPubMedGoogle Scholar
  23. 23.
    Hofman M et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4–10CrossRefPubMedGoogle Scholar
  24. 24.
    Meeske K et al (2007) Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res 16(6):947–960CrossRefPubMedGoogle Scholar
  25. 25.
    Servaes P et al (2007) The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology 16(9):787–795CrossRefPubMedGoogle Scholar
  26. 26.
    Bower JE et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106(4):751–758CrossRefPubMedGoogle Scholar
  27. 27.
    Bower JE et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753PubMedGoogle Scholar
  28. 28.
    Burgess C et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702CrossRefPubMedGoogle Scholar
  29. 29.
    Hjerl K et al (2003) Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44(1):24–30CrossRefPubMedGoogle Scholar
  30. 30.
    Schneider CM et al (2007) Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol 18(12):1957–1962CrossRefPubMedGoogle Scholar
  31. 31.
    Schneider CM et al (2007) Exercise training manages cardiopulmonary function and fatigue during and following cancer treatment in male cancer survivors. Integr Cancer Ther 6(3):235–241CrossRefPubMedGoogle Scholar
  32. 32.
    Valenti M et al (2008) Physical exercise and quality of life in breast cancer survivors. Int J Med Sci 5(1):24–28PubMedGoogle Scholar
  33. 33.
    Carlson LE et al (2006) Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study. Bone Marrow Transplant 37(10):945–954CrossRefPubMedGoogle Scholar
  34. 34.
    Adamsen L et al (2006) The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 14(2):116–127CrossRefPubMedGoogle Scholar
  35. 35.
    Windsor PM, Nicol KF, Potter J (2004) A randomized controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101(3):550–557CrossRefPubMedGoogle Scholar
  36. 36.
    Burnham TR, Wilcox A (2002) Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 34(12):1863–1867CrossRefPubMedGoogle Scholar
  37. 37.
    Mock V et al (2001) Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9(3):119–127CrossRefPubMedGoogle Scholar
  38. 38.
    Schneider CM et al (2007) Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer 110(4):918–925CrossRefPubMedGoogle Scholar
  39. 39.
    Kim CJ et al (2006) Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy. Cancer Nurs 29(2):156–165CrossRefPubMedGoogle Scholar
  40. 40.
    Battaglini C et al (2007) The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment. Sao Paulo Med J 125(1):22–28CrossRefPubMedGoogle Scholar
  41. 41.
    Courneya KS et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404CrossRefPubMedGoogle Scholar
  42. 42.
    Schwartz AL, Winters-Stone K, Gallucci B (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34(3):627–633CrossRefPubMedGoogle Scholar
  43. 43.
    Schwartz AL et al (2001) Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33(5):718–723CrossRefPubMedGoogle Scholar
  44. 44.
    Schwartz AL (2000) Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract 8(1):16–24CrossRefPubMedGoogle Scholar
  45. 45.
    Milne HM et al (2008) Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 108(2):279–288CrossRefPubMedGoogle Scholar
  46. 46.
    Cheema BS, Gaul CA (2006) Full-body exercise training improves fitness and quality of life in survivors of breast cancer. J Strength Cond Res 20(1):14–21CrossRefPubMedGoogle Scholar
  47. 47.
    Sprod LK et al (2005) The effects of walking poles on shoulder function in breast cancer survivors. Integr Cancer Ther 4(4):287–293CrossRefPubMedGoogle Scholar
  48. 48.
    Daley AJ et al (2007) Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol 25(13):1713–1721CrossRefPubMedGoogle Scholar
  49. 49.
    Holmes MD et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486CrossRefPubMedGoogle Scholar
  50. 50.
    Herrero F et al (2006) Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med 27(7):573–580CrossRefPubMedGoogle Scholar
  51. 51.
    Dwyer GB, Davis SE (eds) (2005) ACSM’s health-related physical fitness assessment manual. Lippincott Williams & Wilkins, Philadelphia, 180 ppGoogle Scholar
  52. 52.
    Schneider CM, Dennehy CA, Carter SD (2003) Exercise and cancer recovery. Human Kinetics, Champaign, xi, 219 ppGoogle Scholar
  53. 53.
    Piper BF et al (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMedGoogle Scholar
  54. 54.
    Beck AT et al (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893–897CrossRefPubMedGoogle Scholar
  55. 55.
    Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91(5):822–828PubMedGoogle Scholar
  56. 56.
    Young KE, White CA (2006) The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60(1):29–38CrossRefPubMedGoogle Scholar
  57. 57.
    Hewitt JA et al (2005) Exercise for breast cancer survival: the effect on cancer risk and cancer-related fatigue (CRF). Int J Fertil Womens Med 50(5 Pt 1):231–239PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Lisa K. Sprod
    • 1
    • 2
  • City C. Hsieh
    • 3
  • Reid Hayward
    • 1
  • Carole M. Schneider
    • 1
    Email author
  1. 1.Rocky Mountain Cancer Rehabilitation InstituteUniversity of Northern ColoradoGreeleyUSA
  2. 2.University of RochesterRochesterUSA
  3. 3.Yuanpei UniversityHsinchuTaiwan

Personalised recommendations